keyword
MENU ▼
Read by QxMD icon Read
search

menopur

keyword
https://www.readbyqxmd.com/read/27729967/corifollitropin-stimulation-in-combination-with-gnrh-antagonists-after-estradiol-valerate-pre-treatment-a-pilot-study-on-patientfriendly-ivf
#1
W Decleer, K Verschueren, S Vandeginste, K Osmanagaoglu, P Devroey
OBJECTIVE: To demonstrate the feasibility of scheduling an IVF cycle, without disadvantages, in the new patient friendly stimulation protocol using the long acting Corifollitropin Alfa, in combination with GnRH-antagonist protection and GnRH-agonist triggering. STUDY DESIGN: Two groups of ten patients were admitted in the study. Both received the same stimulation protocol with Corifollitropin Alfa in combination with GnRH-antagonist protection. After ultrasound evaluation on day 7 individually dosed Menopur was added...
December 28, 2015: Facts, Views & Vision in ObGyn
https://www.readbyqxmd.com/read/27581117/economic-evaluation-of-three-frequently-used-gonadotrophins-in-assisted-reproduction-techniques-in-the-management-of-infertility-in-the-netherlands
#2
Vassilis Fragoulakis, Chris P Pescott, Jesper M J Smeenk, Evert J P van Santbrink, G Jur E Oosterhuis, Frank J M Broekmans, Nikos Maniadakis
BACKGROUND AND OBJECTIVE: Subfertility represents a multidimensional problem associated with significant distress and impaired social well-being. In the Netherlands, an estimated 50,000 couples visit their general practitioner and 30,000 couples seek medical specialist care for subfertility. We conducted an economic evaluation comparing recombinant human follicle-stimulating hormone (follitropin alfa, r-hFSH, Gonal-F(®)) with two classes of urinary gonadotrophins-highly purified human menopausal gonadotrophin (hp-HMG, Menopur(®)) and urinary follicle-stimulating hormone (uFSH, Fostimon(®))-for ovarian stimulation in women undergoing in vitro fertilization (IVF) treatment in the Netherlands...
December 2016: Applied Health Economics and Health Policy
https://www.readbyqxmd.com/read/26361207/450-iu-versus-600-iu-gonadotropin-for-controlled-ovarian-stimulation-in-poor-responders-a-randomized-controlled-trial
#3
RANDOMIZED CONTROLLED TRIAL
Jessica Lefebvre, Roland Antaki, Isaac-Jacques Kadoch, Nicola L Dean, Camille Sylvestre, François Bissonnette, Joanne Benoit, Sylvain Ménard, Louise Lapensée
OBJECTIVE: To compare the outcomes of controlled ovarian stimulation/in vitro fertilization cycles using 450 IU and 600 IU gonadotropin per day in women at risk of poor ovarian response. DESIGN: Prospective randomized controlled nonblinded study. SETTING: University-affiliated private IVF center. PATIENT(S): Women considered to be at risk of poor ovarian response: aged <41 years with basal FSH >10 IU/L, antimüllerian hormone <1 ng/mL, antral follicle count ≤ 8, or a previous IVF cycle with ≥ 300 IU/d gonadotropin that resulted in a cancellation, <8 follicles, or <5 oocytes...
December 2015: Fertility and Sterility
https://www.readbyqxmd.com/read/25788569/low-dose-human-menopausal-gonadotrophin-versus-clomiphene-citrate-in-subfertile-couples-treated-with-intrauterine-insemination-a-randomized-controlled-trial
#4
RANDOMIZED CONTROLLED TRIAL
Karen Peeraer, Sophie Debrock, Peter De Loecker, C Tomassetti, A Laenen, M Welkenhuysen, L Meeuwis, S Pelckmans, B W Mol, C Spiessens, D De Neubourg, T M D'Hooghe
STUDY QUESTION: Can controlled ovarian stimulation with low-dose human menopausal gonadotrophin (hMG) improve the clinical pregnancy rate when compared with ovarian stimulation with clomiphene citrate (CC) in an intrauterine insemination (IUI) programme for subfertile couples? SUMMARY ANSWER: Ovarian stimulation with low-dose hMG is superior to CC in IUI cycles with respect to clinical pregnancy rate. WHAT IS KNOWN ALREADY: IUI after ovarian stimulation is an effective treatment for mild male subfertility, unexplained subfertility and minimal-mild endometriosis, but it is unclear which medication for ovarian stimulation is more effective...
May 2015: Human Reproduction
https://www.readbyqxmd.com/read/23638621/a-prospective-randomised-investigator-blind-controlled-clinical-study-on-the-clinical-efficacy-and-tolerability-of-two-highly-purified-hmg-preparations-administered-subcutaneously-in-women-undergoing-ivf
#5
RANDOMIZED CONTROLLED TRIAL
C Alviggi, G E Cognigni, G Morgante, B Cometti, A Ranieri, I Strina, M Filicori, V De Leo, G De Placido
The aim of this multicentre, prospective, randomised, investigator blind, controlled clinical trial was to evaluate the clinical efficacy and tolerability of a highly purified human menopausal gonadotrophin (hMG) preparation (Merional-HG) when administered to patients undergoing controlled ovarian stimulation (COS) for in-vitro fertilisation (IVF) procedure enrolled in hospital departments. One hundred fifty-seven patients were randomised in two parallel groups: 78 started COS with Merional-HG and 79 with Menopur...
July 2013: Gynecological Endocrinology
https://www.readbyqxmd.com/read/22888264/economic-evaluation-of-alternative-assisted-reproduction-techniques-in-management-of-infertility-in-greece
#6
Vassilis Fragoulakis, Georgia Kourlaba, Basil Tarlatzis, Minas Mastrominas, Nikolaos Maniadakis
BACKGROUND: The purpose of this study was to compare Gonal-F(®), a recombinant follicle-stimulating hormone, with Menopur(®), a highly purified human menopausal gonadotrophin (hpHMG) in assisted reproduction in Greece. METHODS: A decision tree in combination with a Markov model was used to assess the clinical and economical impact of comparators for up to three consecutive cycles. Transition probabilities were derived from the literature and validated by clinical experts...
2012: ClinicoEconomics and Outcomes Research: CEOR
https://www.readbyqxmd.com/read/22244781/a-randomized-assessor-blind-trial-comparing-highly-purified-hmg-and%C3%A2-recombinant-fsh-in-a-gnrh-antagonist-cycle-with-compulsory-single-blastocyst-transfer
#7
RANDOMIZED CONTROLLED TRIAL
Paul Devroey, Antonio Pellicer, Anders Nyboe Andersen, Joan-Carles Arce
OBJECTIVE: To compare the efficacy and safety of highly purified menotropin (hphMG) and recombinant FSH (rFSH) for controlled ovarian stimulation in a GnRH antagonist cycle with compulsory single-blastocyst transfer. DESIGN: Randomized, open-label, assessor-blind, parallel groups, multicenter, noninferiority trial. SETTING: Twenty-five infertility centers in seven countries. PATIENT(S): Seven hundred forty-nine women...
March 2012: Fertility and Sterility
https://www.readbyqxmd.com/read/22127004/dose-dependent-effects-of-gonadotropin-on-oocyte-developmental-competence-and-apoptosis
#8
Shan Liu, Huai L Feng, Dennis Marchesi, Zi-Jiang Chen, Avner Hershlag
The aim of the present study was to evaluate the effect of gonadotropins (Gn) on oocyte maturation, developmental competence and apoptosis in an animal model. Bovine cumulus-oocyte complexes (COCs) were matured for 24 h in media supplemented with varying concentrations of Bravelle (B), B + Menopur (B+M) or B + Repronex (B + R) (Ferring Pharmaceuticals, Parsiappany, NJ, USA). Then, nuclear maturation, embryo development, and apoptosis in cumulus cells and oocytes were evaluated. Low to moderate Gn concentrations (75-75 00 mIUmL(-1)) effectively improved nuclear maturation and in vitro development...
2011: Reproduction, Fertility, and Development
https://www.readbyqxmd.com/read/21227944/birth-after-tese-icsi-in-a-man-with-hypogonadotropic-hypogonadism-and-congenital-adrenal-hypoplasia-linked-to-a-dax-1-nr0b1-mutation
#9
C Frapsauce, C Ravel, M Legendre, M Sibony, J Mandelbaum, B Donadille, J C Achermann, J-P Siffroi, S Christin-Maitre
DAX1/NR0B1 mutations are responsible for X-linked congenital adrenal hypoplasia (AHC) associated with hypogonadotropic hypogonadism (HH). Few data are available concerning testicular function and fertility in men with DAX1 mutations. Azoospermia as well as failure of gonadotrophin treatment have been reported. We induced spermatogenesis in a patient who has a DAX1 mutation (c.1210C>T), leading to a stop codon in position 404 (p.Gln404X). His endocrine testing revealed a low testosterone level at 1.2 nmol/l (N: 12-40) with low FSH and LH levels at 2...
March 2011: Human Reproduction
https://www.readbyqxmd.com/read/20389096/clinical-efficacy-of-highly-purified-hmg-versus-recombinant-fsh-in-ivf-icsi-cycles-a-meta-analysis
#10
REVIEW
Byung Chul Jee, Chang Suk Suh, Yong Beom Kim, Seok Hyun Kim, Shin Yong Moon
BACKGROUND/AIMS: To compare the effectiveness of highly purified hMG (Menopur) with recombinant FSH (Gonal-F) in IVF/ICSI patients who underwent ovarian hyperstimulation with pituitary suppression. METHODS: A literature search of the National Library of Medicine and the National Institutes of Health (PubMed), Medline and Cochrane Controlled Trials Register was performed using the key words 'highly purified hMG' and 'recombinant FSH.' Only prospective randomized controlled trials were included when they compared IVF/ICSI outcomes after administration of Menopur versus Gonal-F...
2010: Gynecologic and Obstetric Investigation
https://www.readbyqxmd.com/read/20361702/-woman-with-surgical-reconstruction-of-anal-atresia-who-realized-pregnancy-with-in-vitro-fertilisation
#11
Eliana Garalejić, Biljana Arsić, Dragana Bojović-Jović, Milija Veljković, Biljana Macanović, Dejan Pavlović, Bojan Vasić, Dragana Lekić
INTRODUCTION: Anal atresia is a congenital anomaly, very life-threatening and urgent. Surgical treatment of this anomaly consists of colostomy first, and then of anal reconstruction. CASE REPORT: We presented a 31-year old female with the surgery treatment of anal atresia in the early childhood. In the reproductive period, due to tubal infertily, the patient was included in the program of in vitro fertilization (IVF), in the Clinic for Gynecology and Obstetrics "Narodni front", Belgrade...
March 2010: Vojnosanitetski Pregled. Military-medical and Pharmaceutical Review
https://www.readbyqxmd.com/read/20226040/differential-gene-expression-in-human-granulosa-cells-from-recombinant-fsh-versus-human-menopausal-gonadotropin-ovarian-stimulation-protocols
#12
RANDOMIZED CONTROLLED TRIAL
John Brannian, Kathleen Eyster, Breanne A Mueller, Mandi G Bietz, Keith Hansen
BACKGROUND: The study was designed to test the hypothesis that granulosa cell (GC) gene expression response differs between recombinant FSH and human menopausal gonadotropin (hMG) stimulation regimens. METHODS: Females < 35 years-old undergoing IVF for tubal or male factor infertility were prospectively randomized to one of two stimulation protocols, GnRH agonist long protocol plus individualized dosages of (1) recombinant (r)FSH (Gonal-F) or (2) purified human menopausal gonadotropin (hMG; Menopur)...
March 12, 2010: Reproductive Biology and Endocrinology: RB&E
https://www.readbyqxmd.com/read/19827632/-enhancing-effect-of-androgen-receptor-antagonist-on-gonadotropic-inductors-of-ovulation-in-rats-with-polycystic-ovaries
#13
O H Reznikov, O M Borys, N D Nosenko, P V Sinitsyn, L V Tarasenko, L I Poliakova
Hormonal indices, phase pattern of estrous cycles, and histological structure of the ovaries were studied in female rats with polycystic ovaries caused by subcutaneous implantation of Silastic capsules with testosterone after consecutive treatment with non-steroid antiandrogen, flutamide (flutafarm), urinary FSH (menopur) and HCG (choragon). It was shown that while the plasma testosterone level was increased, administration of the drugs in subtherapeutical doses interrupted persistent diestrus, renewed estrous cycle, gonadal and uterine weights, induced appearance of postovulatory luteal bodies and restored fertility...
2009: Fiziolohichnyĭ Zhurnal
https://www.readbyqxmd.com/read/19268933/live-birth-of-a-normal-mature-healthy-baby-by-in-vitro-fertilization-embryo-transfer-ivf-et-after-an-exploratory-laparotomy-and-multiple-myomectomy-for-leiomyomatosis-peritonealis-disseminata
#14
Sammy L DeAngelis, Robert R Harris, Mitchell A Maiman, Eric S Knochenhauer
OBJECTIVE: To report a case of a live birth of a normal mature healthy baby by IVF-ET after an exploratory laparotomy and multiple myomectomy for leiomyomatosis peritonealis disseminata. DESIGN: Case report. SETTING: Academic university hospital. PATIENT(S): A 37-year-old female G2P0 with secondary infertility diagnosed with leiomyomatosis peritonealis disseminata who underwent surgical resection and IVF stimulation...
May 2009: Fertility and Sterility
https://www.readbyqxmd.com/read/19079958/a-cost-per-live-birth-comparison-of-hmg-and-rfsh-randomized-trials
#15
RANDOMIZED CONTROLLED TRIAL
Mark Connolly, Kathleen De Vrieze, Willem Ombelet, Dirk Schneider, Craig Currie
To help inform healthcare treatment practices and funding decisions, an economic evaluation was conducted to compare the two leading gonadotrophins used for IVF in Belgium. Based on the results of a recently published meta-analysis, a simulated decision tree model was constructed with four states: (i) fresh cycle, (ii) cryopreserved cycle, (iii) live birth and (iv) treatment withdrawal. Gonadotrophin costs were based on highly purified human menopausal gonadotrophin (HP-HMG; Menopur) and recombinant FSH (rFSH) alpha (Gonal-F)...
December 2008: Reproductive Biomedicine Online
https://www.readbyqxmd.com/read/18371963/endometrin-for-luteal-phase-support-in-a-randomized-controlled-open-label-prospective-in-vitro-fertilization-trial-using-a-combination-of-menopur-and-bravelle-for-controlled-ovarian-hyperstimulation
#16
RANDOMIZED CONTROLLED TRIAL
Kevin J Doody, Vicki L Schnell, Russell A Foulk, Charles E Miller, Bradford A Kolb, Emily J Blake, Vladimir I Yankov
OBJECTIVE: To assess the efficacy and safety of a vaginal progesterone (P(4)) insert (Endometrin) for luteal support for assisted reproductive technology (ART). DESIGN: Multicenter, randomized, open-label (assessor-blinded) phase III clinical trial. SETTING: Twenty-five U.S. ART centers. PATIENT(S): A total of 1,211 ART patients randomized to three groups: Endometrin 100 mg twice daily (n = 404), Endometrin 100 mg three times daily (n = 404), and P(4) 90 mg 8% gel daily (n = 403)...
April 2009: Fertility and Sterility
https://www.readbyqxmd.com/read/18339384/cost-saving-treatment-strategies-in-in-vitro-fertilization-a-combined-economic-evaluation-of-two-large-randomized-clinical-trials-comparing-highly-purified-human-menopausal-gonadotropin-and-recombinant-follicle-stimulating-hormone-alpha
#17
RANDOMIZED CONTROLLED TRIAL
Jaroslaw Wechowski, Mark Connolly, Dirk Schneider, Philip McEwan, Richard Kennedy
OBJECTIVE: To assess the cost-effectiveness of two gonadotropin treatments that are available in the United Kingdom in light of limited public funding and the fundamental role of costs in IVF treatment decisions. DESIGN: An economic evaluation based on two large randomized clinical trials in IVF patients using a simulation model. SETTING: Fifty-three fertility clinics in 13 European countries and Israel. PATIENT(S): Women indicated for treatment with IVF (N = 986), aged 18-38, participating in double-blind, randomized controlled trials...
April 2009: Fertility and Sterility
https://www.readbyqxmd.com/read/17640944/influence-of-ovarian-stimulation-with-hp-hmg-or-recombinant-fsh-on-embryo-quality-parameters-in-patients-undergoing-ivf
#18
RANDOMIZED CONTROLLED TRIAL
Søren Ziebe, Kersti Lundin, Ronny Janssens, Lisbeth Helmgaard, Joan-Carles Arce
BACKGROUND: There are limited data on the impact of different gonadotrophin preparations on embryo quality. METHODS: This evaluation was part of a randomized, assessor-blind, multinational trial, conducted in 731 women undergoing IVF after stimulation with highly purified human menopausal gonadotropin (HP-hMG; MENOPUR) (n = 363) or recombinant FSH (rFSH; GONAL-F) (n = 368). Ongoing pregnancy was the primary end-point [HP-hMG 27% and rFSH 22%; odds ratio (OR) (95% confidence interval, CI) 1...
September 2007: Human Reproduction
https://www.readbyqxmd.com/read/17110397/endocrine-profile-in-serum-and-follicular-fluid-differs-after-ovarian-stimulation-with-hp-hmg-or-recombinant-fsh-in-ivf-patients
#19
RANDOMIZED CONTROLLED TRIAL
J Smitz, A N Andersen, P Devroey, J-C Arce
BACKGROUND: Highly purified menotrophin (HP-hMG) has been associated with fewer oocytes retrieved and a higher proportion of top-quality embryos compared with recombinant FSH (rFSH). METHODS: A randomized, assessor-blind, multinational trial in 731 women undergoing IVF after stimulation with HP-hMG (MENOPUR) (n = 363) or rFSH (GONAL-F) (n = 368) following a long GnRH agonist protocol was conducted. Blood was collected before, during and after stimulation. Fluid was collected from follicles > or =17 mm...
March 2007: Human Reproduction
https://www.readbyqxmd.com/read/16571641/similar-ovulation-rates-but-different-follicular-development-with-highly-purified-menotrophin-compared-with-recombinant-fsh-in-who-group-ii-anovulatory-infertility-a-randomized-controlled-study
#20
RANDOMIZED CONTROLLED TRIAL
Peter Platteau, Anders Nyboe Andersen, Adam Balen, Paul Devroey, Per Sørensen, Lisbeth Helmgaard, Joan-Carles Arce
BACKGROUND: The contribution of the LH activity in menotrophin preparations for ovulation induction has been investigated in small trials conducted versus FSH preparations. The objective of this study was to demonstrate non-inferiority of highly purified urinary menotrophin (HP-HMG) versus recombinant FSH (rFSH) with respect to the primary outcome measure, ovulation rate. METHODS: This was a randomized, open-label, assessor-blind, multinational study. Women with anovulatory infertility WHO Group II and resistant to clomiphene citrate were randomized (computer-generated list) to stimulation with HP-HMG (n=91) or rFSH (n=93) using a low-dose step-up protocol...
July 2006: Human Reproduction
keyword
keyword
98752
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"